摘要
目的观察国产替罗非班在冠状动脉介入治疗术治疗急性冠脉综合征中的临床应用。方法59例ACS患者PCI术中应用国产替罗非班,与同期常规PCI术治疗的患者相比,评价国产替罗非班在ACS中的效果。结果PCI术中出现慢血流或无血流现象应用国产替罗非班38例,血流明显改善29例。国产替罗非班组出血2例。结论国产替罗非班对改善冠脉PCI术慢血流、无再流有明显作用,能预防术后血栓形成,值得深入研究。
Objective To observe the effect of Tirofiban made in China during PCI operation in ACS patients. Methods Fifty-nine ACS patients used Tirofiban during PCI operation, compared with the routine group, and we evaluated effect of Tirofiban in ACS. Results Thirty-eight patients used Tirofiban during PCI operation. Twenty-nine patients had improved TIMI flow. Two patients had bleed in Tirofiban group. Conclusion Tirofiban made in china can improve TIMI flow significantly and prevent thrombosis, it is worthy for more research.
出处
《中国现代医生》
2008年第6期44-45,共2页
China Modern Doctor
关键词
急性冠脉综合征
冠状动脉介入治疗
国产替罗非班
Acute coronary syndrome
Percutaneous coronary intervention
Tirofiban made in China
